UFT, a compound containing uracil and tegafur (a prodrug of 5-fluorouracil) in a 4:1 molar ratio, has been used in Japan for the treatment of and as adjuvant chemotherapy for bladder cancer. In phase II studies, 300 to 600
Masahiko Hosaka, MD, PhD
Advertisement
Articles by Masahiko Hosaka, MD, PhD
Advertisement
Latest Updated Articles
- UFT in Bladder Cancer
Published: July 1st 1999 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
2
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
3
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
4
AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights
5
